24 August 2017 - Deborah Wilkes
Archived
Sweden's Karo Pharma is set to acquire Norwegian consumer healthcare company Weifa – including its Paracet and Ibux pain relievers – in a deal worth NOK1.28 billion (USD0.16 billion).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.